Open AccessReport on trial death stokes Alzheimer’s drug fears
Author(s) -
Charles Piller
Publication year - 2023
Publication title -
science
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.adi2242
Subject(s) - drug trial , clearing , drug , key (lock) , medicine , amyloid (mycology) , clinical trial , pharmacology , pathology , business , computer security , computer science , finance
Amyloid-clearing antibody lecanemab faces key FDA hearing in June.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom